Anti-human MRC2 / CD280 (Quark patent Anti-ENDO 180 Biosimilar) Metabotropic glutamate receptor 5 Steel factor

Steel factor

Conjugation None Clone# Onartuzumab Formulation 100 mM Pro-Ac 20mM Arg pH 5

pheo-chromocytomas

3ml RTU -20°C 9 Counter Staining Reagent 5ml RTU RT 10 Differentiation Reagent 6ml RTU RT 11 Mounting Media 5ml RTU RT 12 Control slide (Mouse kidney) 1 slide RTU RT 13 Datasheet 1 copy

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Mouse CD138 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L / HRP) 6ml RTU 2-8°C 7 Chromogen Component A 0

Anti-human MRC2 / CD280 (Quark patent Anti-ENDO 180 Biosimilar) Metabotropic glutamate receptor 5 Steel factorApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name MRC2 CD280 Target Uniprot Q9UBG0 Overview Catalog# BIO0725SM Product Name Anti human MRC2 CD280 (Quark patent Anti ENDO 180 Biosimilar) Specifications Conjugation None Clone# Quark patent Anti ENDO 180 Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve